Table 1 Characteristics, treatment, and outcome of pediatric patients with angioimmunoblastic lymphoma
Study | Number of patients | Age | Sex | Treatment | Outcome |
|---|---|---|---|---|---|
Howarth and Bird [7] | 1 | 7 years | Male | Prednisolone and vincristine | D |
Fiorillo et al. [8] | 1 | 8 years | Male | Supportive | L |
de Terlizzi et al. [9] | 1 | 14 months | Male | Prednisolone and vincristine | D |
Horneff et al. [10] | 1 | 13 years | Female | Prednisolone | L |
Kobayashi et al. [11] | 1 | 14 years | Male | JACLS NHL98T | L |
Windsor et al. [5] | 3 | 14 years | Female | Prednisolone | D |
7 years | Male | UKALL X | L | ||
3 years | Male | CHOP | D | ||
Mellgren et al. [15] | 4 | Median 12.5 years | 3 males 1 female | NR | 3 L 1 D |
Kraus et al. [20] | 1 | 8 years | Male | Cyclophosphamide Etoposide Vincristine Prednisone | L |
Our case | 1 | 3 years | Male | Observation | L |